Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Coiled Thera (COIL) Share Price

Price 11.75p on 02-06-2026 at 16:35:12
Change 0.00p 0%
Buy 12.50p
Sell 11.00p
Last Trade: Sell 13,054.00 at 11.49p
Day's Volume: 83,635
Last Close: 11.75p
Open: 11.75p
ISIN: GB00BSHRN331
Day's Range 11.75p - 11.75p
52wk Range: 6.75p - 12.00p
Market Capitalisation: £50.04m
VWAP: 11.52527p
Shares in Issue: 425.86m

Coiled Thera (COIL) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 13,054 11.49p Ordinary
14:52:42 - 02-Jun-26
Sell* 503 11.587p Ordinary
14:05:42 - 02-Jun-26
Sell* 10,000 11.49p Ordinary
13:14:03 - 02-Jun-26
Sell* 6,044 11.49p Ordinary
12:16:09 - 02-Jun-26
Buy* 140 12.50p SI Trade
12:16:06 - 02-Jun-26
Buy* 10 12.50p SI Trade
12:16:06 - 02-Jun-26
Buy* 13 12.50p SI Trade
12:16:06 - 02-Jun-26
Buy* 368 12.50p SI Trade
12:13:51 - 02-Jun-26
Sell* 20 11.00p SI Trade
12:13:51 - 02-Jun-26
Sell* 193 11.00p SI Trade
12:13:51 - 02-Jun-26
See more Coiled Thera trades

Coiled Thera (COIL) Share Price History

Time period:
to
Date Open High Low Close Volume
2nd Jun 2026 (Tue) 11.75 11.75 11.75 11.75 83,635
1st Jun 2026 (Mon) 11.75 11.75 11.10 11.75 149,138
29th May 2026 (Fri) 11.75 11.75 10.90 10.90 154,919
28th May 2026 (Thu) 11.30 12.00 12.00 12.00 878,535
27th May 2026 (Wed) 11.25 12.00 11.30 11.30 939,665
26th May 2026 (Tue) 11.75 11.75 11.25 11.25 1,620,130
25th May 2026 (Mon) 11.75 11.75 11.75 11.75 0
22nd May 2026 (Fri) 10.75 11.75 10.00 11.75 717,860
21st May 2026 (Thu) 10.25 10.75 10.25 10.75 1,054,100
20th May 2026 (Wed) 10.00 11.00 11.00 11.00 680,546
19th May 2026 (Tue) 8.75 10.25 8.75 10.00 559,520
18th May 2026 (Mon) 8.00 8.75 8.00 8.75 741,973
15th May 2026 (Fri) 8.00 8.25 8.00 8.00 460
14th May 2026 (Thu) 8.00 8.25 8.00 8.00 10,465
13th May 2026 (Wed) 8.00 8.25 8.00 8.00 141,120
12th May 2026 (Tue) 8.00 8.00 8.00 8.00 0
11th May 2026 (Mon) 7.50 8.00 7.50 8.00 969,469
8th May 2026 (Fri) 7.50 7.50 7.50 7.50 40,000
7th May 2026 (Thu) 8.00 8.00 7.50 7.50 3,619
6th May 2026 (Wed) 7.50 8.00 7.50 7.50 42,999
5th May 2026 (Tue) 7.95 7.95 7.50 7.50 103
4th May 2026 (Mon) 7.50 7.50 7.50 7.50 0
See more Coiled Thera price history

Coiled Thera (COIL) Regulatory News

Date Source Headline
29th May 2026 7:00 am RNS Issue of Equity
27th May 2026 7:00 am RNS Notice of Annual General Meeting
19th May 2026 7:00 am RNS Commencement of Trading on US OTCQB Venture Market
7th May 2026 7:01 am RNS-R Attendance at Endless Frontier Labs 2026
7th May 2026 7:00 am RNS Appointment of Non-Executive Director
6th May 2026 7:00 am RNS Annual Report & Financial Statements
15th Apr 2026 7:00 am RNS-R Presentation at 18th Annual World Cancer Congress
8th Apr 2026 7:00 am RNS Clinical Trial Update
1st Apr 2026 7:00 am RNS Total Voting Rights
27th Mar 2026 7:00 am RNS Admission to Trading and First Day of Dealings
See more Coiled Thera regulatory news

Coiled Thera (COIL) Share News

Coiled Therapeutics shares rise as cross trading begins in New York

19th May 2026 14:25

(Alliance News) - Coiled Therapeutics PLC on Tuesday reported its US trading launch. Read More

WINNERS & LOSERS: Forterra falls; Thor Explorations earnings up

19th May 2026 10:02

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

EARNINGS: Dauch reports first-quarter loss but sales jump 69%

8th May 2026 14:33

(Alliance News) - The following is a round-up of earnings reports by London-listed companies, issued on Friday, Wednesday and Tuesday, and not separately reported by Alliance News: Read More

WINNERS & LOSERS: Energy stocks up; Wise gains on growth update

13th Apr 2026 11:49

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More

IN BRIEF: Coiled Therapeutics shares jump as hails inhibitor benefit

8th Apr 2026 14:06

Coiled Therapeutics PLC - London-based clinical stage oncology company - Giving a clinical trial update, company announces that regarding advanced solid tumour cancers, its brain-penetrant inhibitor AO-252 delivered an 80% clinical benefit rate when transitioned to a twice-daily dosing regimen, compared to 40% observed in the once-daily cohort. The firm says 80% of evaluable patients in the twice-daily cohort achieved tumour stabilisation or regression, with treatment durations exceeding six months. "This substantially outperforms the two to three month benchmark typically seen with salvage therapy in this heavily pre-treated population," Coiled adds. Read More

See more Coiled Thera news
FTSE 100 Latest
Value10,373.51
Change34.56

Login to your account

Forgot Password?

Not Registered